A citation-based method for searching scientific literature

Margaret A Knowles, Carolyn D Hurst. Nat Rev Cancer 2015
Times Cited: 551







List of co-cited articles
436 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.
A Gordon Robertson, Jaegil Kim, Hikmat Al-Ahmadie, Joaquim Bellmunt, Guangwu Guo, Andrew D Cherniack, Toshinori Hinoue, Peter W Laird, Katherine A Hoadley, Rehan Akbani,[...]. Cell 2017
768
30


Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
24

Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends.
Sebastien Antoni, Jacques Ferlay, Isabelle Soerjomataram, Ariana Znaor, Ahmedin Jemal, Freddie Bray. Eur Urol 2017
17

Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy.
Woonyoung Choi, Sima Porten, Seungchan Kim, Daniel Willis, Elizabeth R Plimack, Jean Hoffman-Censits, Beat Roth, Tiewei Cheng, Mai Tran, I-Ling Lee,[...]. Cancer Cell 2014
849
16

Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology.
Jeffrey S Damrauer, Katherine A Hoadley, David D Chism, Cheng Fan, Christopher J Tiganelli, Sara E Wobker, Jen Jen Yeh, Matthew I Milowsky, Gopa Iyer, Joel S Parker,[...]. Proc Natl Acad Sci U S A 2014
460
15

A Consensus Molecular Classification of Muscle-invasive Bladder Cancer.
Aurélie Kamoun, Aurélien de Reyniès, Yves Allory, Gottfrid Sjödahl, A Gordon Robertson, Roland Seiler, Katherine A Hoadley, Clarice S Groeneveld, Hikmat Al-Ahmadie, Woonyoung Choi,[...]. Eur Urol 2020
174
14

Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial.
Jonathan E Rosenberg, Jean Hoffman-Censits, Tom Powles, Michiel S van der Heijden, Arjun V Balar, Andrea Necchi, Nancy Dawson, Peter H O'Donnell, Ani Balmanoukian, Yohann Loriot,[...]. Lancet 2016
14

EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.
Marko Babjuk, Andreas Böhle, Maximilian Burger, Otakar Capoun, Daniel Cohen, Eva M Compérat, Virginia Hernández, Eero Kaasinen, Joan Palou, Morgan Rouprêt,[...]. Eur Urol 2017
13

Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer.
J Alfred Witjes, Thierry Lebret, Eva M Compérat, Nigel C Cowan, Maria De Santis, Harman Maxim Bruins, Virginia Hernández, Estefania Linares Espinós, James Dunn, Mathieu Rouanne,[...]. Eur Urol 2017
789
12

Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma.
Joaquim Bellmunt, Ronald de Wit, David J Vaughn, Yves Fradet, Jae-Lyun Lee, Lawrence Fong, Nicholas J Vogelzang, Miguel A Climent, Daniel P Petrylak, Toni K Choueiri,[...]. N Engl J Med 2017
12

Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma.
Yohann Loriot, Andrea Necchi, Se Hoon Park, Jesus Garcia-Donas, Robert Huddart, Earle Burgess, Mark Fleming, Arash Rezazadeh, Begoña Mellado, Sergey Varlamov,[...]. N Engl J Med 2019
296
11

Epidemiology and risk factors of urothelial bladder cancer.
Maximilian Burger, James W F Catto, Guido Dalbagni, H Barton Grossman, Harry Herr, Pierre Karakiewicz, Wassim Kassouf, Lambertus A Kiemeney, Carlo La Vecchia, Shahrokh Shariat,[...]. Eur Urol 2013
960
11

Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma.
Jakob Hedegaard, Philippe Lamy, Iver Nordentoft, Ferran Algaba, Søren Høyer, Benedicte Parm Ulhøi, Søren Vang, Thomas Reinert, Gregers G Hermann, Karin Mogensen,[...]. Cancer Cell 2016
266
11

European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update.
Marko Babjuk, Maximilian Burger, Eva M Compérat, Paolo Gontero, A Hugh Mostafid, Joan Palou, Bas W G van Rhijn, Morgan Rouprêt, Shahrokh F Shariat, Richard Sylvester,[...]. Eur Urol 2019
330
11

Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.
Richard J Sylvester, Adrian P M van der Meijden, Willem Oosterlinck, J Alfred Witjes, Christian Bouffioux, Louis Denis, Donald W W Newling, Karlheinz Kurth. Eur Urol 2006
10

Molecular classification of urothelial carcinoma: global mRNA classification versus tumour-cell phenotype classification.
Gottfrid Sjödahl, Pontus Eriksson, Fredrik Liedberg, Mattias Höglund. J Pathol 2017
140
9

TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.
Sanjeev Mariathasan, Shannon J Turley, Dorothee Nickles, Alessandra Castiglioni, Kobe Yuen, Yulei Wang, Edward E Kadel, Hartmut Koeppen, Jillian L Astarita, Rafael Cubas,[...]. Nature 2018
9

Next-generation Sequencing of Nonmuscle Invasive Bladder Cancer Reveals Potential Biomarkers and Rational Therapeutic Targets.
Eugene J Pietzak, Aditya Bagrodia, Eugene K Cha, Esther N Drill, Gopa Iyer, Sumit Isharwal, Irina Ostrovnaya, Priscilla Baez, Qiang Li, Michael F Berger,[...]. Eur Urol 2017
136
8

A molecular taxonomy for urothelial carcinoma.
Gottfrid Sjödahl, Martin Lauss, Kristina Lövgren, Gunilla Chebil, Sigurdur Gudjonsson, Srinivas Veerla, Oliver Patschan, Mattias Aine, Mårten Fernö, Markus Ringnér,[...]. Clin Cancer Res 2012
425
8

EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype.
Sandra Rebouissou, Isabelle Bernard-Pierrot, Aurélien de Reyniès, May-Linda Lepage, Clémentine Krucker, Elodie Chapeaublanc, Aurélie Hérault, Aurélie Kamoun, Aurélie Caillault, Eric Letouzé,[...]. Sci Transl Med 2014
170
8

Bladder cancer.
Ashish M Kamat, Noah M Hahn, Jason A Efstathiou, Seth P Lerner, Per-Uno Malmström, Woonyoung Choi, Charles C Guo, Yair Lotan, Wassim Kassouf. Lancet 2016
497
8

Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy.
Roland Seiler, Hussam Al Deen Ashab, Nicholas Erho, Bas W G van Rhijn, Brian Winters, James Douglas, Kim E Van Kessel, Elisabeth E Fransen van de Putte, Matthew Sommerlad, Natalie Q Wang,[...]. Eur Urol 2017
348
8

European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines.
J Alfred Witjes, Harman Max Bruins, Richard Cathomas, Eva M Compérat, Nigel C Cowan, Georgios Gakis, Virginia Hernández, Estefania Linares Espinós, Anja Lorch, Yann Neuzillet,[...]. Eur Urol 2021
129
8

Cancer statistics, 2019.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2019
8

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
7

Genomic Subtypes of Non-invasive Bladder Cancer with Distinct Metabolic Profile and Female Gender Bias in KDM6A Mutation Frequency.
Carolyn D Hurst, Olivia Alder, Fiona M Platt, Alastair Droop, Lucy F Stead, Julie E Burns, George J Burghel, Sunjay Jain, Leszek J Klimczak, Helen Lindsay,[...]. Cancer Cell 2017
107
7

Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial.
Arjun V Balar, Matthew D Galsky, Jonathan E Rosenberg, Thomas Powles, Daniel P Petrylak, Joaquim Bellmunt, Yohann Loriot, Andrea Necchi, Jean Hoffman-Censits, Jose Luis Perez-Gracia,[...]. Lancet 2017
939
7

Cancer statistics, 2020.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2020
7

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.
Ethan Cerami, Jianjiong Gao, Ugur Dogrusoz, Benjamin E Gross, Selcuk Onur Sumer, Bülent Arman Aksoy, Anders Jacobsen, Caitlin J Byrne, Michael L Heuer, Erik Larsson,[...]. Cancer Discov 2012
6

Intratumoral Heterogeneity of Bladder Cancer by Molecular Subtypes and Histologic Variants.
Joshua I Warrick, Gottfrid Sjödahl, Matthew Kaag, Jay D Raman, Suzanne Merrill, Lauren Shuman, Guoli Chen, Vonn Walter, David J DeGraff. Eur Urol 2019
74
8

Molecular Drivers of the Non-T-cell-Inflamed Tumor Microenvironment in Urothelial Bladder Cancer.
Randy F Sweis, Stefani Spranger, Riyue Bao, Gladell P Paner, Walter M Stadler, Gary Steinberg, Thomas F Gajewski. Cancer Immunol Res 2016
173
6

Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use.
Vipulkumar Dadhania, Miao Zhang, Li Zhang, Jolanta Bondaruk, Tadeusz Majewski, Arlene Siefker-Radtke, Charles C Guo, Colin Dinney, David E Cogdell, Shizhen Zhang,[...]. EBioMedicine 2016
138
6

Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial.
Thomas Powles, Ignacio Durán, Michiel S van der Heijden, Yohann Loriot, Nicholas J Vogelzang, Ugo De Giorgi, Stéphane Oudard, Margitta M Retz, Daniel Castellano, Aristotelis Bamias,[...]. Lancet 2018
584
6

The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part B: Prostate and Bladder Tumours.
Peter A Humphrey, Holger Moch, Antonio L Cubilla, Thomas M Ulbright, Victor E Reuter. Eur Urol 2016
586
6

Molecular Subtypes of Urothelial Bladder Cancer: Results from a Meta-cohort Analysis of 2411 Tumors.
Tuan Zea Tan, Mathieu Rouanne, Kien Thiam Tan, Ruby Yun-Ju Huang, Jean-Paul Thiery. Eur Urol 2019
93
6

The Tumor Immune Microenvironment Drives a Prognostic Relevance That Correlates with Bladder Cancer Subtypes.
Carolin Pfannstiel, Pamela L Strissel, Katherine B Chiappinelli, Danijel Sikic, Sven Wach, Ralph M Wirtz, Adrian Wullweber, Helge Taubert, Johannes Breyer, Wolfgang Otto,[...]. Cancer Immunol Res 2019
56
10

Bladder cancer.
Oner Sanli, Jakub Dobruch, Margaret A Knowles, Maximilian Burger, Mehrdad Alemozaffar, Matthew E Nielsen, Yair Lotan. Nat Rev Dis Primers 2017
249
6

Treatment of muscle-invasive and advanced bladder cancer in 2020.
Vaibhav G Patel, William K Oh, Matthew D Galsky. CA Cancer J Clin 2020
42
14

A Molecular Pathologic Framework for Risk Stratification of Stage T1 Urothelial Carcinoma.
Oliver Patschan, Gottfrid Sjödahl, Gunilla Chebil, Kristina Lövgren, Martin Lauss, Sigurdur Gudjonsson, Petter Kollberg, Pontus Eriksson, Mattias Aine, Wiking Månsson,[...]. Eur Urol 2015
74
6

Recurrence of high-risk bladder cancer: a population-based analysis.
Karim Chamie, Mark S Litwin, Jeffrey C Bassett, Timothy J Daskivich, Julie Lai, Jan M Hanley, Badrinath R Konety, Christopher S Saigal. Cancer 2013
149
5

TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urine.
Isaac Kinde, Enrico Munari, Sheila F Faraj, Ralph H Hruban, Mark Schoenberg, Trinity Bivalacqua, Mohamad Allaf, Simeon Springer, Yuxuan Wang, Luis A Diaz,[...]. Cancer Res 2013
164
5

Bladder Cancer Molecular Taxonomy: Summary from a Consensus Meeting.
Seth P Lerner, David J McConkey, Katherine A Hoadley, Keith S Chan, William Y Kim, François Radvanyi, Mattias Höglund, Francisco X Real. Bladder Cancer 2016
119
5

Management of metastatic bladder cancer.
Rosa Nadal, Joaquim Bellmunt. Cancer Treat Rev 2019
70
7

Genomic complexity of urothelial bladder cancer revealed in urinary cfDNA.
Fiona S Togneri, Douglas G Ward, Joseph M Foster, Adam J Devall, Paula Wojtowicz, Sofia Alyas, Fabiana Ramos Vasques, Assa Oumie, Nicholas D James, K K Cheng,[...]. Eur J Hum Genet 2016
70
7

The economics of bladder cancer: costs and considerations of caring for this disease.
Robert S Svatek, Brent K Hollenbeck, Sten Holmäng, Richard Lee, Simon P Kim, Arnulf Stenzl, Yair Lotan. Eur Urol 2014
259
5

Signatures of mutational processes in human cancer.
Ludmil B Alexandrov, Serena Nik-Zainal, David C Wedge, Samuel A J R Aparicio, Sam Behjati, Andrew V Biankin, Graham R Bignell, Niccolò Bolli, Ake Borg, Anne-Lise Børresen-Dale,[...]. Nature 2013
5

Mutational heterogeneity in cancer and the search for new cancer-associated genes.
Michael S Lawrence, Petar Stojanov, Paz Polak, Gregory V Kryukov, Kristian Cibulskis, Andrey Sivachenko, Scott L Carter, Chip Stewart, Craig H Mermel, Steven A Roberts,[...]. Nature 2013
5

Molecular and histopathology directed therapy for advanced bladder cancer.
Constantine Alifrangis, Ursula McGovern, Alex Freeman, Thomas Powles, Mark Linch. Nat Rev Urol 2019
48
10

Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer.
Hans von der Maase, Lisa Sengelov, James T Roberts, Sergio Ricci, Luigi Dogliotti, T Oliver, Malcolm J Moore, Annamaria Zimmermann, Michael Arning. J Clin Oncol 2005
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.